Source comparison
PT-141 Results Timeline: Dose Comparison
The table below summarizes PT-141 results timeline differences across the three most common research doses. These are clinical reference ranges only. Not personal recommendations. And individual response varies based on receptor density, body composition, and
This comparison does not assign a generated winner or score.
- The table below summarizes PT-141 results timeline differences across the three most common research doses. These are clinical reference ranges only. Not personal recommendations. And individual response varies based on receptor density, body composition, and prior exposure.
- 0.75mg
- 60–90 minutes
- 3–4 hours
- 6–8 hours
- 10–15%
- Minimal effective dose. Slower onset, milder peak intensity, lower adverse event rate; suitable for first-time trials or subjects sensitive to nausea
- 1.5mg
- 45–60 minutes
- 2–3 hours
- 8–10 hours
- 25–30%
- Standard research dose. Predictable PT-141 results timeline, robust arousal enhancement, moderate nausea risk; most published trials use this dose
- 2.0mg
- 30–45 minutes
- 2–2.5 hours
- 8–12 hours
- 35–40%
- High-intensity dose. Fastest onset, most pronounced peak, longest duration, but nausea approaches 40%; reserved for subjects who tolerated 1.5mg without significant adverse effects